NCT03657719View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 13, 2018

Study Completion Date

December 13, 2018

Conditions
Influenza, Human
Interventions
BIOLOGICAL

GC3114

High-dose Quadrivalent influenza vaccine

BIOLOGICAL

GCFLU Quadrivalent

Quadrivalent influenza vaccine

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY